Physician

Sushma N Pandrangi, M.D.

According to 2025 Medicare claims, Sushma Pandrangi, M.D. (NPI: 1306981014) practices nephrology in the Monroe, MI market, with the plurality of this provider's patient population coming from Monroe, MI. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF MICHIGAN PC (NPI: 1922249366; TIN: 264239523) and primary practice location at 48161-1434.

Pandrangi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 588 traditional Medicare patients, billed 7,517 HCPCS/CPT codes, and received $169,382 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,203 prescription claims across 330 beneficiaries totaling $225,987 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2017 DME data shows 27 claims. Open Payments data shows 3 records totaling $36. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $311,507 to $169,382. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $200,284 and ending at $225,987. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	743	30,972	$311,507
2016	765	27,391	$288,348
2017	817	29,203	$324,826
2018	757	18,653	$342,185
2019	812	20,022	$310,620
2020	725	10,674	$287,871
2021	670	8,915	$283,078
2022	576	6,719	$239,764
2023	646	18,908	$215,772
2024	588	7,517	$169,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	261	1,036	$200,284
2016	221	903	$142,102
2017	221	858	$136,333
2018	282	996	$149,808
2019	308	1,124	$128,238
2020	284	971	$106,475
2021	308	1,083	$158,640
2022	280	934	$92,087
2023	328	1,151	$193,741
2024	330	1,203	$225,987

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	27	$518
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	98	104	$130
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	51	73	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	216	533	$61
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	192	229	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	196	244	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	20	690	$75,627
Farxiga	Dapagliflozin Propanediol	77	3,930	$70,120
Lokelma	Sodium Zirconium Cyclosilicate	16	860	$19,592
Jardiance	Empagliflozin	15	930	$17,819
Sevelamer Carbonate	Sevelamer Carbonate	50	2,930	$13,769

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$36	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sushma N. Pandrangi, M.D.?

Tedicare shows public-source Medicare data for Sushma N. Pandrangi, M.D. (NPI 1306981014), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sushma N. Pandrangi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sushma N. Pandrangi, M.D.?

Sushma N. Pandrangi, M.D. is linked to NEPHROLOGY ASSOCIATES OF MICHIGAN PC (billing NPI 1922249366) in the available physician profile data.

Does Sushma N. Pandrangi, M.D. have Open Payments data?

Sushma N. Pandrangi, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.